{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:04:58Z","timestamp":1761491098071,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education, Youth and Sports","doi-asserted-by":"publisher","award":["NV-17\/31593A"],"award-info":[{"award-number":["NV-17\/31593A"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.imlet.2020.09.009","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T01:34:42Z","timestamp":1601861682000},"page":"64-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3965-1807","authenticated-orcid":false,"given":"Kate\u0159ina","family":"Roubalov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0160\u00e1rka","family":"N\u011bme\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitka","family":"Kry\u0161tofov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Hainz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark\u00e9ta","family":"Pumannov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Ham\u0161\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2020.09.009_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(19)30107-0","article-title":"Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 european conference on infections in leukaemia (ECIL 7)","author":"Ljungman","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.imlet.2020.09.009_bib0010","doi-asserted-by":"crossref","first-page":"e12677","DOI":"10.1111\/tid.12677","article-title":"Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with Fludarabine, Busulfan, and anti-thymocyte globulin myeloablative conditioning","volume":"19.3","author":"Lam","year":"2017","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.imlet.2020.09.009_bib0015","first-page":"803","article-title":"Management of Epstein-Barr virus infections and Post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation","volume":"101.7","author":"Styczynski","year":"2016"},{"key":"10.1016\/j.imlet.2020.09.009_bib0020","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived t lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12.10","author":"Leen","year":"2006","journal-title":"Nat. Med."},{"issue":"Suppl 11","key":"10.1016\/j.imlet.2020.09.009_bib0025","doi-asserted-by":"crossref","first-page":"S966","DOI":"10.1093\/clind\/13.Supplement_11.S966","article-title":"Cytotoxic t cells specific for cytomegalovirus: a potential therapy for immunocompromised patients","volume":"13","author":"Riddell","year":"1991","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.imlet.2020.09.009_bib0030","article-title":"MHC class I-Associated phosphopeptides are the targets of memory-like immunity in Leukemia","volume":"5.203","author":"Cobbold","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imlet.2020.09.009_bib0035","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/cid\/cis625","article-title":"Rapid salvage treatment with virus-specific t cells for therapy-resistant disease","volume":"55","author":"Uhlin","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.imlet.2020.09.009_bib0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/ciq042","article-title":"Directly selected cytomegalovirus-reactive donor t cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation","volume":"52.1","author":"Peggs","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.imlet.2020.09.009_bib0045","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1186\/s12967-014-0336-5","article-title":"Rapid generation of clinical-grade antiviral t cells: selection of suitable T-Cell donors and GMP-Compliant manufacturing of antiviral t cells","volume":"12.1","author":"Tischer","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.imlet.2020.09.009_bib0050","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/CCO.0000000000000580","article-title":"Adoptive cell therapies for posttransplant infections","volume":"31.6","author":"Sutrave","year":"2019","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.imlet.2020.09.009_bib0055","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.bbmt.2018.08.024","article-title":"Establishment and operation of a third-party virus-specific t cell bank within an allogeneic stem cell transplant program","volume":"24","author":"Withers","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.imlet.2020.09.009_bib0060","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-Shelf virus-specific t cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.imlet.2020.09.009_bib0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13045-019-0701-1","article-title":"Strategies of adoptive t -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation","volume":"12","author":"Kaeuferle","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.imlet.2020.09.009_bib0070","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/jmv.24440","article-title":"Seroprevalence Rates of HPyV6, HPyV7, TSPyV, HPyV9, MWPyV and KIPyV Polyomaviruses among the healthy blood donors","volume":"88","author":"\u0160roller","year":"2016","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.imlet.2020.09.009_bib0075","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4110\/in.2015.15.4.186","article-title":"Cytomegalovirus infection and memory t cell inflation","volume":"15","author":"Kim","year":"2015","journal-title":"Immune Netw."},{"key":"10.1016\/j.imlet.2020.09.009_bib0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/imr.12653","article-title":"The (Gradual) rise of memory inflation","volume":"283","author":"Klenerman","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2020.09.009_bib0085","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum t cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imlet.2020.09.009_bib0090","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein-Barr virus","volume":"25","author":"Hislop","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2020.09.009_bib0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/cei.12427","article-title":"A mutation in X-Linked inhibitor of apoptosis (G466X) leads to memory inflation of Epstein-Barr virus-specific t cells: XIAP deficiency inflates EBV t cell responses","volume":"178","author":"Lopez-Granados","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2020.09.009_bib0100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imr.12435","article-title":"Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications","volume":"272","author":"Afridi","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2020.09.009_bib0105","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/mt.2012.130","article-title":"Rapidly generated multivirus-specific cytotoxic t lymphocytes for the prophylaxis and treatment of viral infections","volume":"20","author":"Gerdemann","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.imlet.2020.09.009_bib0110","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2009-07-232454","article-title":"Cytotoxic t lymphocyte therapy with donor t cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation","volume":"114","author":"Leen","year":"2009","journal-title":"Blood"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247820303886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247820303886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:38:44Z","timestamp":1759045124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247820303886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":22,"alternative-id":["S0165247820303886"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2020.09.009","relation":{},"ISSN":["0165-2478"],"issn-type":[{"type":"print","value":"0165-2478"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2020.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}